These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7790172)

  • 21. Health care technology assessment and transfer.
    Boos N
    Eur Spine J; 2007 Aug; 16(8):1291-2. PubMed ID: 17636348
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of health technology assessment in shaping the benefits package in The Netherlands.
    Stolk EA; de Bont A; van Halteren AR; Bijlmer RJ; Poley MJ
    Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):85-94. PubMed ID: 19371181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health technology assessment: for whom the bell tolls?
    Garattini L; Casadei G
    Eur J Health Econ; 2008 Nov; 9(4):311-2. PubMed ID: 18543010
    [No Abstract]   [Full Text] [Related]  

  • 24. Researcher-driven versus policy-driven economic appraisal of health technologies: the case of France.
    Moatti JP; Chanut C; Benech JM
    Soc Sci Med; 1994 Jun; 38(12):1625-33. PubMed ID: 8047920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health technology assessment and comparative effectiveness research: a pharmaceutical industry perspective.
    Hao Y; Thomas A
    Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):447-54. PubMed ID: 23977973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
    Wallner PE; Konski A
    J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Indirect costs in health technology assessment].
    Jakubczyk M; Wrona W; Macioch T; Golicki D; Niewada M; Hermanowski T
    Pol Merkur Lekarski; 2010 Jan; 28(163):42-5. PubMed ID: 20369723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A regulatory governance perspective on health technology assessment (HTA) in France: the contextual mediation of common functional pressures.
    Barron AJ; Klinger C; Shah SM; Wright JS
    Health Policy; 2015 Feb; 119(2):137-46. PubMed ID: 25458970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Technology development from the perspective of industry.
    Abele JE
    J Invasive Cardiol; 1993 Mar; 5(2):65-8. PubMed ID: 10171667
    [No Abstract]   [Full Text] [Related]  

  • 30. The UK market today and tomorrow.
    Kreuzer M
    Med Device Technol; 2002 Dec; 13(10):39-40. PubMed ID: 12575530
    [No Abstract]   [Full Text] [Related]  

  • 31. [Economic health technology assessment: challenges and perspectives].
    Zerda A
    Biomedica; 2014; 34(2):161-3. PubMed ID: 24967920
    [No Abstract]   [Full Text] [Related]  

  • 32. Health technology assessment in health-care decisions in the United States.
    Sullivan SD; Watkins J; Sweet B; Ramsey SD
    Value Health; 2009 Jun; 12 Suppl 2():S39-44. PubMed ID: 19523183
    [No Abstract]   [Full Text] [Related]  

  • 33. Strategies for technology assessment and implementation in some European countries.
    Stocking B
    Int J Technol Assess Health Care; 1986; 2(1):19-26. PubMed ID: 10276247
    [No Abstract]   [Full Text] [Related]  

  • 34. Imaging devices spread more thinly in Canada.
    Brice J
    Diagn Imaging (San Franc); 1990 Mar; 12(3):137-45. PubMed ID: 10149352
    [No Abstract]   [Full Text] [Related]  

  • 35. Reflections on the evolution of health technology assessment in Europe.
    Sorenson C; Chalkidou K
    Health Econ Policy Law; 2012 Jan; 7(1):25-45. PubMed ID: 22221927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic data transferability for HTA: are we there yet?
    Manca A
    Value Health; 2009 Jun; 12(4):407. PubMed ID: 19900247
    [No Abstract]   [Full Text] [Related]  

  • 37. Dynamic modeling in medical technology assessment. Fitting hearing aids in The Netherlands.
    Boas G; van der Stel H; Peters H; Joore M; Anteunis L
    Int J Technol Assess Health Care; 2001; 17(4):618-25. PubMed ID: 11758306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High cost technology in health care: a benefit or a burden?
    Rutten FF; Bonsel GJ
    Soc Sci Med; 1992 Aug; 35(4):567-77. PubMed ID: 1519110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Technology assessment in medicine: methods, status and trends.
    Hendee WR
    Med Prog Technol; 1991; 17(2):69-75. PubMed ID: 1835752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the impact of health technology assessment.
    Jacob R; McGregor M
    Int J Technol Assess Health Care; 1997; 13(1):68-80. PubMed ID: 9119625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.